5 questions on CRISPR-Cas with Sandeep Rajan

2026-09-01T08:46:22+01:001 September 2026|

From bacterial defence to breakthrough therapies, we explore how CRISPR-Cas is transforming research and healthcare, and how experts at the Wellcome Sanger Institute are refining the technology to make genome editing more scalable and effective.

Unlocking the genetics of skin cancer

2024-11-12T11:17:26+00:0012 November 2024|

Dr David Adams, Senior Group Leader at the Wellcome Sanger Institute, is a pioneer in cancer biology and uncovering skin cancer genetics. We explore his 20-year career at Sanger and the global impact of his research.

Nine billion and counting – Mapping the human variants and their effects on health and disease

2024-05-15T13:42:40+01:0016 January 2024|

The Atlas of Variant Effects Alliance celebrates its fourth year this month.  A collaboration of multiple institutes, including the Wellcome Sanger Institute, the Alliance has the aim of assessing the effects of all variants in our genomes. In this blog, we highlight the Alliance’s achievements and the diverse community underpinning such a colossal effort.

Building an atlas of gene variants to understand health and disease

2024-05-21T15:20:14+01:007 August 2023|

Mutational scanning technologies are revolutionising the way we understand human genetic variation. A symposium in July brought together researchers from over 50 countries to explore the possibilities of this incipient genomic method, and how it can benefit clinicians and patients.

Accidental Entrepreneur

2024-07-05T10:42:40+01:0023 March 2023|

In this third part of our innovator blog series, we spoke to Matt Hurles, Head of the Human Genetics programme and incoming Director of the Wellcome Sanger Institute. Matt defines himself as an accidental entrepreneur, even though he spearheads a number of innovative initiatives that showcase his motivation to ultimately bring benefits to patients.